AbbVie Reports First-Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. NVDA
2. PCVX
3. PTC
4. MSFT
5. SPY
6. META
7. GOOGL
8. GMAB
9. AMD
10. BBIO

Go back to AbbVie Reports First-Quarter 2023 Financial Results

AbbVie (ABBV) shares slide despite revenue beat

April 27, 2023 8:55 AM EDT

AbbVie (NYSE: ABBV) shares are tumbling premarket, currently down over 6% after the company reported its first-quarter earnings, which saw it report in-line profits and a revenue beat but miss sales estimates for some of its major drugs.

The company reported Q1 EPS of... More

AbbVie (ABBV) Reports In-Line Q1 EPS, Offers Guidance

April 27, 2023 7:34 AM EDT

AbbVie (NYSE: ABBV) reported Q1 EPS of $2.46, in-line with the analyst estimate of $2.46. Revenue for the quarter came in at $12.23 billion versus the consensus estimate of $12.18 billion.

GUIDANCE:

AbbVie sees FY2023 EPS of $10.72-$11.12, versus the consensus of $10.94.

For earnings history and earnings-related data on AbbVie (ABBV) click here.

... More